Journals
Publish with us
Publishing partnerships
About us
Blog
Stem Cells International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Stem Cells International
/
2021
/
Article
/
Tab 2
/
Review Article
Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Table 2
Subgroup analysis.
Responder analyses
6 months
12 months
24 months
36 months
Overall effect
Pain responder
MIC in VAS
[1.10, 5.84],
[1.22, 6.36],
[0.93, 4.48],
[0.67, 3.34],
[1.43, 3.25],
CSC in VAS
[1.14, 5.90],
[1.31, 7.12],
[0.76, 4.16],
[0.71, 3.71],
[1.44, 3.31],
ODI responder
MIC in ODI
[0.95, 4.92],
[0.84, 4.15],
[0.93, 4.84],
[0.93, 4.84],
[1.37, 3.10],
CSC in ODI
[0.71, 3.58],
[0.82, 4.23],
[0.88, 4.47],
[1.17, 6.74],
[1.33, 3.05],